drug prices Archives - Ashvinmedicara

Socioeconomic Genocide: The Silent Crisis of Healthcare Access How America is Killing Itself

Brian RogersJune 4, 20240379 views

The rising cost of prescription drugs in the United States disproportionately impacts Latino, Black, and immigrant communities, exacerbating existing health disparities. Economic barriers and chronic health conditions are prevalent among these groups, who often face significant obstacles to accessing necessary medications. This systemic issue, driven by corporate greed and governmental negligence, calls for urgent reforms to ensure universal healthcare access and address the socio-economic “genocide” affecting the less wealthy. By prioritizing affordability, access, and equity in healthcare, we can begin to mitigate these deep-rooted disparities.

American Policy Failures: The Blocking of Affordable Medications from Abroad

Brian RogersJune 4, 20240118 views

The debate over healthcare and drug prices in the United States highlights significant socio-economic disparities. Higher-income individuals often oppose universal healthcare due to concerns over financial responsibility, while lower-income communities and minorities face substantial barriers to accessing healthcare and healthy food, exacerbating chronic health conditions. High medication costs lead to non-adherence, particularly among those with lower incomes and seniors, resulting in unmanaged health issues and increased hospitalizations. Addressing these disparities requires recognizing the broader socio-economic factors and implementing policies that ensure equitable access to healthcare and medications for all Americans.

Health or Wealth? The Cost of Big Pharma’s Influence on U.S. Healthcare Policy

Brian RogersMay 29, 20240122 views

Year after year, the pharmaceutical industry ranks among the top spenders in lobbying efforts in Washington, D.C., pouring hundreds of millions into influencing drug approval processes and pricing. This financial influence secures patents and market exclusivity for new drugs, creating monopolies that keep prices high and limit affordable alternatives. Platforms like Ashvin Medicara offer transparency and education about cost-effective pharmaceuticals. It’s crucial for the public to demand open dialogues and reforms to prioritize accessible and affordable healthcare for all.